Dental News - BioHorizons CAMLOG—Inspiring excellence in oral reconstruction

Search Dental Tribune

BioHorizons CAMLOG—Inspiring excellence in oral reconstruction

From left: Renè Willi, President Global Dental Surgical Group Henry Schein, Markus Stammen, Manging Director CAMLOG GER, Todd Strong, Chief Technology Officer, Michael Ludwig, CEO of CAMLOG GER, Holger Essig, Chief Marketing Officer, Martin Lugert, Managing Director Sales CAMLOG GER and Christian Rähle, Director Research and Development. (Photograph: OEMUS MEDIA)


Sat. 16. March 2019


COLOGNE, Germany: At IDS 2019, BioHorizons CAMLOG is presenting a variety of innovations for implant-based tooth replacement. The comprehensive lines of dental implants, restorative components, and CAD/CAM and regenerative solutions are tailored to the diverse individual needs of today’s clinical challenges in daily practice.

Todd Strong, Chief Technology Officer of BioHorizons CAMLOG, said: “We are convinced that our comprehensive, evidence-based and scientifically proven portfolio of products offers ideal solutions for the individual preferences of today’s implantologists and specialists.”

Since 2016, BioHorizons and CAMLOG, the premium implant companies within Henry Schein’s Global Dental Surgical Group, have pursued an evolutionary pathway to combine their strengths. At first, BioHorizons and CAMLOG unified their go-to-market approach in all subsidiary markets, using their complementary strengths. In 2018, the international sales channels were combined, creating five regional sales organisations, thus enabling local customer centricity in each market and focus on the fast-growing international markets.

“We always focus on our people—especially during transformation. Trust and loyalty within the organisation are the basis. Building an inspiring and empowering culture is key to winning in today’s fast-changing environment,” said Dr René Willi, President of the Global Dental Surgical Group at Henry Schein.

The new combined group branding of BioHorizons CAMLOG marks a subsequent milestone in the combination of two industry-leading companies to grow jointly on a global scale while reinforcing the identity of both established brands. CAMLOG will continue to be the leading brand in the German-speaking markets, and BioHorizons will continue to lead in the Americas.

This year, CAMLOG is celebrating 20 years of continued success. A very important factor is the teams’ evolutionary spirit. That spirit is based on cooperation, strong partnerships, learning from others, lateral thinking which leads to new horizons, transferring ideas and spirit into business, and helping customers grow their practices. This is accomplished by offering value-added services and education beyond implants.

“We would like to thank all our customers for the valuable insights provided, helping us to develop and grow our solution portfolio, and for their loyalty and support,” said Martin Lugert, Managing Director of Sales at CAMLOG Germany.

To post a reply please login or register